Advertisement

Topics

Companies Related to "Sobi Inc." [Most Relevant Company Matches] [Advanced Search Results] RSS

09:04 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "Sobi Inc." found in our extensive corporate database of over 50,000 company records.

Showing "Sobi" Companies, all 6

Extremely Relevant

Swedish Orphan Biovitrum AB

Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families. Sobi have a diversified and growth-oriented commercial product portfolio. Sobi's key therapeutic areas are Inflammation and Genetics & Metabolism. Sobi's late stage pipeline includes three phase III progra...


Relevant

Sobi

Sobi is an international specialty healthcare company dedicated to rare diseases. Sobi’s mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Haemophilia, Inflammation and Genetic diseases. Sobi also markets a portfolio of specialty and rare disease products ...

Sobi Inc.


Probably Relevant

Biogen and Sobi

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and inno...

Bioverativ Inc. & Sobi

Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies. Launched in 2017 following separation from Biogen Inc., Bioverativ builds upon a strong heritage of scientific i...

Bioverativ Inc. and Sobi

Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development and commercialization of innovative therapies. Launched in 2017 following separation from Biogen Inc., Bioverativ builds upon a strong heritage of scientific i...


More From BioPortfolio on "Sobi Inc."

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks